ASAHI INTECC develops and supplies wire materials and products to the industries inside and outside Japan using an integrated in-house production system based on our four advanced core technologies that covers everything from selection and treatment of raw materials to manufacture of final products. In the medical field, ASAHI INTECC develops and manufacturers original brand products such as PTCA guidewires, as well as OEM products, some of which have become world standards.
Covidien/ev3 is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. We are committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today – peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons.
The Medtronic Mission continues to unite all of us worldwide to serve patients by alleviating pain, restoring health, and extending lives. As part of the Endovascular Therapies business, we contribute to this mission through our vascular innovations that span from head to toe. In the lower extremities, our therapies alleviate claudication, restore mobility and salvage limbs. Additionally, our carotid portfolio of therapies prevents stroke, a leading cause of disability and mortality worldwide. Along with our coronary, renal denervation and aortic technologies, we are committed to meeting the needs of physicians and patients in cardiovascular disease care.
Specialized in acrylic resins, since 1981, we work closely with surgeons to develop innovative, safe and effective products. Our goal is to improve the quality of life of patients: in this perspective and thanks to our constant research and development efforts, combined with major technological advances in industrial processes, we were the first to launch innovative products on the market.
Through its multi-modality platform, Volcano Corporation is the global leader in intravascular imaging for coronary and peripheral applications, and physiology. The company also offers a suite of peripheral therapeutic devices. The company’s broad range of technologies make imaging and therapy simpler, more informative and less invasive. Volcano offers physicians and their patients around the world industry leading tools that aid diagnosis and guide and provide therapy. Founded in cardiovascular care and expanding into other specialties, Volcano is focused on improving patient and economic outcomes.